These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38351003)

  • 21. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy.
    Wang Y; Song J; Yu K; Nie D; Zhao C; Jiao L; Wang Z; Zhou L; Wang F; Yu Q; Zhang S; Wen Z; Wu J; Wang CY; Wang DW; Cheng J; Zhao C
    Hypertension; 2023 Oct; 80(10):2099-2111. PubMed ID: 37485661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.
    Mondanelli G; Coletti A; Greco FA; Pallotta MT; Orabona C; Iacono A; Belladonna ML; Albini E; Panfili E; Fallarino F; Gargaro M; Manni G; Matino D; Carvalho A; Cunha C; Maciel P; Di Filippo M; Gaetani L; Bianchi R; Vacca C; Iamandii IM; Proietti E; Boscia F; Annunziato L; Peppelenbosch M; Puccetti P; Calabresi P; Macchiarulo A; Santambrogio L; Volpi C; Grohmann U
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3848-3857. PubMed ID: 32024760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling.
    Huang T; Song J; Gao J; Cheng J; Xie H; Zhang L; Wang YH; Gao Z; Wang Y; Wang X; He J; Liu S; Yu Q; Zhang S; Xiong F; Zhou Q; Wang CY
    Nat Commun; 2022 Jun; 13(1):3489. PubMed ID: 35715443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of endurance training and nettle leaf extract on the IDO1-KYN-AHR pathway homeostasis and inhibiting of liver toxicity in rats with STZ-induced diabetes.
    Haghshenas R; Aftabi Y; Doaei S; Gholamalizadeh M
    Front Endocrinol (Lausanne); 2023; 14():1071424. PubMed ID: 37305057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells
    Amobi-McCloud A; Muthuswamy R; Battaglia S; Yu H; Liu T; Wang J; Putluri V; Singh PK; Qian F; Huang RY; Putluri N; Tsuji T; Lugade AA; Liu S; Odunsi K
    Front Immunol; 2021; 12():678999. PubMed ID: 34025677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
    Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
    Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
    Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives.
    Peyraud F; Guegan JP; Bodet D; Cousin S; Bessede A; Italiano A
    Front Immunol; 2022; 13():807271. PubMed ID: 35173722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4
    Wang F; Liu M; Ma D; Cai Z; Liu L; Wang J; Zhang W; Zhao L; Zhai C; Xu Y
    Int Immunopharmacol; 2023 Mar; 116():109758. PubMed ID: 36706593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
    Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
    Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10.
    Fang X; Guo L; Xing Z; Shi L; Liang H; Li A; Kuang C; Tao B; Yang Q
    Pharmacol Res; 2022 Mar; 177():106132. PubMed ID: 35183714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
    Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
    Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer.
    Liang H; Li T; Fang X; Xing Z; Zhang S; Shi L; Li W; Guo L; Kuang C; Liu H; Yang Q
    Cancer Lett; 2021 Dec; 522():32-43. PubMed ID: 34520819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell transplantation uncovers TDO-AHR regulation of lung dendritic cells in herpesvirus-induced pathology.
    Gurczynski SJ; Pereira NL; Hrycaj SM; Wilke C; Zemans RL; Moore BB
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33491663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
    Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
    J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mannose receptor negatively modulates the Toll-like receptor 4-aryl hydrocarbon receptor-indoleamine 2,3-dioxygenase axis in dendritic cells affecting T helper cell polarization.
    Salazar F; Hall L; Negm OH; Awuah D; Tighe PJ; Shakib F; Ghaemmaghami AM
    J Allergy Clin Immunol; 2016 Jun; 137(6):1841-1851.e2. PubMed ID: 26703454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.
    Vogel CF; Goth SR; Dong B; Pessah IN; Matsumura F
    Biochem Biophys Res Commun; 2008 Oct; 375(3):331-5. PubMed ID: 18694728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.
    Abuin-Martínez C; Vidal R; Gutiérrez-López MD; Pérez-Hernández M; Giménez-Gómez P; Morales-Puerto N; O'Shea E; Colado MI
    Neuropharmacology; 2021 Apr; 187():108490. PubMed ID: 33607146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergetic impact of combined navoximod with cisplatin mitigates chemo-immune resistance via blockading IDO1
    Chen F; Zhao D; Huang Y; Wen X; Feng S
    Life Sci; 2023 Dec; 335():122239. PubMed ID: 37944638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
    Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
    Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.